122
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Triazavirine supramolecular complexes as modifiers of the peptide oligomeric structure

ORCID Icon, ORCID Icon, & ORCID Icon
Pages 2694-2698 | Received 20 Jun 2017, Accepted 06 Aug 2017, Published online: 12 Sep 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Yana A. Zabrodskaya, Alexey V. Shvetsov, Vladimir B. Tsvetkov & Vladimir V. Egorov. (2019) A double-edged sword: supramolecular complexes of triazavirine display multicenter binding effects which influence aggregate formation. Journal of Biomolecular Structure and Dynamics 37:12, pages 3041-3047.
Read now

Articles from other publishers (5)

Ya. A. Zabrodskaya, A. V. Shvetsov, Yu. P. Garmay, D. V. Lebedev, R. Dattani & V. V. Egorov. (2021) Supramolecular Complexes of Tetrapeptides Capable of Inducing the Human α-Lactalbumin β-Domain Conformational Transitions. Crystallography Reports 66:5, pages 840-845.
Crossref
D. V. Lebedev, V. V. Egorov, A. V. Shvetsov, Y. A. Zabrodskaya, V. V. Isaev-Ivanov & A. L. Konevega. (2021) Neutron Scattering Techniques and Complementary Methods for Structural and Functional Studies of Biological Macromolecules and Large Macromolecular Complexes. Crystallography Reports 66:2, pages 242-253.
Crossref
Sergey V. Valiulin, Andrey A. Onischuk, Sergey N. Dubtsov, Anatoly M. Baklanov, Sergey V. An'kov, Maria E. Plokhotnichenko, Tatyana G. Tolstikova, Galina G. Dultseva, Vladimir L. Rusinov, Valery N. Charushin & Vasily M. Fomin. (2021) Aerosol Inhalation Delivery of Triazavirin in Mice: Outlooks for Advanced Therapy Against Novel Viral Infections. Journal of Pharmaceutical Sciences 110:3, pages 1316-1322.
Crossref
Malak Kaddoura, Malak AlIbrahim, Ghina Hijazi, Nadia Soudani, Amani Audi, Habib Alkalamouni, Salame Haddad, Ali Eid & Hassan Zaraket. (2020) COVID-19 Therapeutic Options Under Investigation. Frontiers in Pharmacology 11.
Crossref
O. V. Gaisenok. (2020) The use of viral RNA polymerase inhibitors in combination with a fusion inhibitor in the treatment of patients with COVID-19: hypothesis. Problems of Virology 65:3, pages 167-175.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.